Found 23 matching trials
Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease PHASE2 This study will be conducted in three parallel groups receiving oxycodone, ...
Show More Location
Hospital of Aix-en-Provence
Learn More & Join Trial
Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants PHASE2 The purpose of this study is to evaluate the efficacy, safety and pharmacok...
Show More Location
Multiple Locations
Learn More & Join Trial
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain PHASE3 To Determine the Safety and Efficacy of Oxycodone / Naloxone Prolonged Rele...
Show More Location
Fuzhou General Hospital of Nanjing Military Command of PLA
Learn More & Join Trial
A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery PHASE4 The aim of the study is to describe the effects of oxycodone/naloxone combi...
Show More Location
Tampere University Hospital Heart Center
Learn More & Join Trial
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy PHASE3 The primary research objective is to demonstrate that subjects taking OXN P...
Show More Location
Ballygomartin Group Practice
Learn More & Join Trial
Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component. PHASE4 This was a clinical effectiveness trial designed to compare the effectivene...
Show More Learn More & Join Trial
Relieving Acute Pain (RAP) Study: A Pilot Study PHASE2 The United States (US) faces a crisis of pain management. According to the ...
Show More Location
University of Maryland
Learn More & Join Trial
Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur PHASE4 Effective treatment of pain after hip fractures is very important but diffi...
Show More Location
Orthopaedic Department
Learn More & Join Trial
OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects PHASE3 The primary objectives are
* to demonstrate that the treatment with OXN PR...
Show More Location
Multiple Locations
Learn More & Join Trial
Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms PHASE3 The primary objective for the 12-week Titration-/Maintenance Period is:
To...
Show More Location
Paracelsus Elena Klinik
Learn More & Join Trial